{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:58:10Z","timestamp":1778954290632,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.intimp.2010.08.018","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T04:58:04Z","timestamp":1284785884000},"page":"1318-1324","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacokinetics of a F(ab\u2032)2 scorpion antivenom administered intramuscularly in healthy human volunteers"],"prefix":"10.1016","volume":"10","author":[{"given":"Hilda","family":"V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Ch\u00e1vez-Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Garc\u00eda-Ubbelohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Paniagua-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Alag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Sevcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2010.08.018_bb0005","unstructured":"Norma Oficial Mexicana NOM-033-SSA2-2002. Para la vigilancia, prevenci\u00f3n y control de la picadura de alacr\u00e1n. Secretar\u00eda de Salud, M\u00e9xico."},{"key":"10.1016\/j.intimp.2010.08.018_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.intimp.2010.01.005","article-title":"Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab\u2032)2, IgG and IgG(T) fragments from hyper immune equine plasma","volume":"10","author":"V\u00e1zquez","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2010.08.018_bb0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1442-2026.2002.00356.x","article-title":"Failure of intramuscular antivenom in Red-back spider envenoming","volume":"14","author":"Isbister","year":"2002","journal-title":"Emerg Med"},{"key":"10.1016\/j.intimp.2010.08.018_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0041-0101(02)00283-0","article-title":"Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: comparison between Fab and IgG","volume":"41","author":"Chaves","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/emj.2004.020727","article-title":"Low dose of snake antivenom is as effective as high dose in patients with severe snake envenoming","volume":"22","author":"Agarwal","year":"2005","journal-title":"Emerg Med J"},{"key":"10.1016\/j.intimp.2010.08.018_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1742-6723.2005.00720.x","article-title":"A double-blind, randomized trial of intravenous versus intramuscular antivenom for Red-back spider envenoming","volume":"17","author":"Ellis","year":"2005","journal-title":"Emerg Med Aust"},{"key":"10.1016\/j.intimp.2010.08.018_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.2007.03004.x","article-title":"A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom","volume":"65","author":"Isbister","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.intimp.2010.08.018_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/qjmed\/hcn048","article-title":"A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism\u2014the RAVE study","volume":"101","author":"Isbister","year":"2008","journal-title":"Q J Med"},{"key":"10.1016\/j.intimp.2010.08.018_bb0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.toxicon.2005.08.010","article-title":"Pharmacokinetics of a F(ab\u2032)2 scorpion antivenom in healthy human volunteers","volume":"46","author":"V\u00e1zquez","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0050","unstructured":"L\u00f3pez de Silanes, J., Mancilla-Nava, R., Paniagua-Sol\u00eds., J.F. Pharmaceutical composition of F(ab\u2032)2 antibody fragments. Patent No. PCT\/MX05\/000071. Instituto Bioclon, S.A. de C.V., Mexico, 2004. Freely available from http:\/\/www.freepatentsonline.com\/7485303.html?query=PN\/US7485303%2520OR%2520US7485303&stemming=on."},{"key":"10.1016\/j.intimp.2010.08.018_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0041-0101(00)00204-X","article-title":"Clinical symptoms observed in children envenomed by scorpion stings, at children's hospital from the State of Morelos, Mexico","volume":"39","author":"Osnaya-Romero","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0060","series-title":"Nonparametric statistical procedures","author":"Hollander","year":"1973"},{"key":"10.1016\/j.intimp.2010.08.018_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1055\/s-0029-1207589","article-title":"\u00dcber das zustandeommen der diphterieimmunit\u00e4t und der tetanusimmunit\u00e4t bei thieren","volume":"16","author":"Von Behring","year":"1890","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.intimp.2010.08.018_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF01832882","article-title":"\u00dcber nat\u00fcrliche Immunit\u00e4t und ihre Verwertung f\u00fcr die Immunisierungstherapie","volume":"31","author":"Klemperer","year":"1893","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"10.1016\/j.intimp.2010.08.018_bb0075","first-page":"720","article-title":"Propri\u00e9t\u00e9s du s\u00e9rum des animaux immunis\u00e9s contre le venin des serpents et th\u00e9rapeutique de l'envenimation","volume":"68","author":"Calmette","year":"1894","journal-title":"CR Acad Sci"},{"key":"10.1016\/j.intimp.2010.08.018_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0041-0101(89)90175-X","article-title":"Epidemiological characteristics of scorpion sting in Leon, Guanajuato, Mexico","volume":"27","author":"Dehesa-Davila","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0041-0101(94)90383-2","article-title":"Scorpionism and serotherapy in Mexico","volume":"32","author":"Dehesa-Davila","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0090","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1378\/chest.97.6.1478","article-title":"Scorpion sting induced pulmonary edema","volume":"97","author":"Rahav","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2010.08.018_bb0095","first-page":"398","article-title":"Non cardiac pulmonary edema in scorpion bite","volume":"41","author":"Mathur","year":"1993","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.intimp.2010.08.018_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0041-0101(98)00180-9","article-title":"Tityus discrepans venom produces a respiratory distress syndrome in rabbits through an indirect mechanism","volume":"37","author":"D'Suze","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0105","unstructured":"The Merck Manuals On Line Medical Library. http:\/\/www.merck.com\/mmhe\/index.html."},{"key":"10.1016\/j.intimp.2010.08.018_bb0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.toxicon.2004.07.032","article-title":"Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab\u2032)2 extrusion mechanism from blood to tissues","volume":"44","author":"Sevcik","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.toxicon.2007.05.011","article-title":"Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab\u2032)2 antivenoms and other drugs","volume":"50","author":"Sevcik","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2010.08.018_bb0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nm0303-269","article-title":"Immunotherapy: past, present and future","volume":"9","author":"Waldmann","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2010.08.018_bb0125","series-title":"ADAPT II User's guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"D'Argenio","year":"1997"},{"key":"10.1016\/j.intimp.2010.08.018_bb0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A simplex method for function minimization","volume":"7","author":"Nelder","year":"1965","journal-title":"Comput J"},{"key":"10.1016\/j.intimp.2010.08.018_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1109\/MCS.1982.1103756","article-title":"Large ordinary differential equation systems and software","volume":"2","author":"Hindmarsh","year":"1982","journal-title":"IEEE Control Syst Mag"},{"key":"10.1016\/j.intimp.2010.08.018_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1137\/0904010","article-title":"Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations","volume":"4","author":"Petzold","year":"1983","journal-title":"SIAM J Sci Stat Comput"},{"key":"10.1016\/j.intimp.2010.08.018_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0169-2607(88)90102-2","article-title":"Simulation of linear compartment models with application to nuclear medicine kinetic modelling","volume":"27","author":"D'Argenio","year":"1988","journal-title":"Comput Meth Programs Biomed"},{"key":"10.1016\/j.intimp.2010.08.018_bb0150","series-title":"Applied numerical methods","author":"Carnahan","year":"1969"},{"key":"10.1016\/j.intimp.2010.08.018_bb0155","series-title":"Association for Applied Human Pharmacology (AGAH)","article-title":"Collection of terms, symbols, equations, and explanations of common pharmacokinetic and pharmacodynamic parameters and some statistical functions","author":"Blode","year":"2004"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910002729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910002729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T19:53:32Z","timestamp":1544212412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576910002729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1567576910002729"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2010.08.018","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}